Spyre Therapeutics
SYRE
#4930
Rank
NZ$2.47 B
Marketcap
$42.17
Share price
3.16%
Change (1 day)
46.09%
Change (1 year)

Market capitalization of Spyre Therapeutics (SYRE)

Market cap: NZ$2.47 Billion

As of December 2024 Spyre Therapeutics has a market cap of NZ$2.47 Billion. This makes Spyre Therapeutics the world's 4930th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Spyre Therapeutics from 2016 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$2.47 B101.96%
2023NZ$1.22 B2712.17%
2022NZ$43.58 M-87.3%
2021NZ$0.34 B-34.39%
2020NZ$0.52 B58.55%
2019NZ$0.32 B22.4%
2018NZ$0.26 B112.6%
2017NZ$0.12 B50.32%
2016NZ$84.34 M

End of Day market cap according to different sources

On Dec 22nd, 2024 the market cap of Spyre Therapeutics was reported to be:

NZ$2.16 Billion
by Nasdaq info icon info icon
NZ$2.47 Billion
by CompaniesMarketCap info icon info icon